SOURCE: King & Spalding

May 06, 2008 09:00 ET

Prominent Medical Device Lawyer Joins King & Spalding

WASHINGTON, DC--(Marketwire - May 6, 2008) - King & Spalding announced today that Seth H. Lundy, an experienced healthcare lawyer who concentrates on providing regulatory counseling to medical technology companies and healthcare providers and suppliers, has joined the firm as a partner in its nationally recognized FDA/healthcare group. Lundy, who has more than 10 years' experience in healthcare law, focuses on fraud and abuse counseling (anti-kickback, Stark/self-referral and false claim laws), Medicare and Medicaid reimbursement and healthcare compliance programs. He is resident in the firm's Washington, D.C., office.

"Seth is a strong addition to our team," said John T. Bentivoglio, co-head of King & Spalding's FDA/healthcare group. "He has a well-earned reputation as a leading healthcare lawyer, and his experience advising medical technology companies complements our large FDA regulatory practice."

Mark S. Brown, co-head of the firm's FDA/healthcare group, said, "Seth's regulatory and compliance experience, coupled with the firm's substantial litigation capabilities, further enhances our ability to handle the most challenging legal and enforcement matters for FDA-regulated companies."

Before joining King & Spalding, Lundy was a partner with Fulbright & Jaworski L.L.P., in Washington, D.C.

Lundy earned a B.A., cum laude, from Amherst College and a J.D., with honors, from The George Washington University Law School.

"I am delighted to be joining King & Spalding's FDA/healthcare group. The firm's reputation in the healthcare industry, particularly in the medical device sector, its remarkably talented lawyers and its focus on growth offer extraordinary opportunities for someone with my experience," Lundy said.

King & Spalding bolstered its FDA/healthcare practice earlier this year when it opened California offices in Silicon Valley and San Francisco that focus, in part, on FDA/healthcare matters including pharmaceutical and medical device product liability litigation.

King & Spalding's FDA/healthcare group consists of 38 attorneys and non-attorney professional consultants who advise pharmaceutical, medical device and biotechnology companies on FDA and healthcare regulatory issues, compliance program development and implementation, internal investigations and enforcement issues. More than a dozen members of this group served previously as lawyers or consultants in various roles at the U.S. Food and Drug Administration, U.S. Department of Health and Human Services and U.S. Department of Justice. King & Spalding represents more than 200 FDA-regulated companies, including 15 of the top 20 pharmaceutical companies and 12 of the top 20 medical device companies.

About King & Spalding

King & Spalding is an international law firm with more than 800 lawyers in Atlanta, Austin, Charlotte, Dubai, Frankfurt, Houston, London, New York, Riyadh (affiliated office), San Francisco, Silicon Valley and Washington, D.C. The firm represents half of the Fortune 100 and in a Corporate Counsel survey in September 2007 was among the top firms representing Fortune 250 companies. For additional information, visit

Contact Information